TDC
ASXC

Thompson Davis & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Thompson Davis & Co’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$277K Buy
3,679
+3,294
+856% +$223K 0.6% 42
2018
Q2 		$22K Buy
+385
New +$14K 0.05% 301
2016
Q3 		– Sell
-77
Closed -$1K – 1198
2016
Q2 		$1K Buy
+77
New +$2.42K ﹤0.01% 1030

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Davis & Co's ASXC Position: Q3 2018 in Review

Thompson Davis & Co increased its Asensus Surgical, Inc. (ASXC) stake by 856% in Q3 2018, buying an estimated $223K and bringing the position to 3,679 shares worth $277K. The position accounts for 0.6% of the portfolio, ranked #42.

Thompson Davis & Co first reported a position in ASXC in Q2 2016 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold ASXC as of Q3 2018.

  • Thompson Davis & Co held 3,679 shares of Asensus Surgical, Inc. worth $277K as of Q3 2018.
  • Thompson Davis & Co bought 3,294 Asensus Surgical, Inc. shares in Q3 2018, an estimated $223K.
  • Asensus Surgical, Inc. made up 0.6% of Thompson Davis & Co's portfolio in Q3 2018, its #42 holding.
  • Thompson Davis & Co first reported a position in Asensus Surgical, Inc. in Q2 2016 and has held it in 3 quarters since.
  • 151 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.